Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 859-867

  Rodríguez Calvo, Teresa ^a,b   Rojas, José Manuel ^a   Martín, Verónica ^a   Sevilla, Noemí ^a  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHEEP; SIGNAL TRANSDUCTION; SPLEEN CELL; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; BLUETONGUE; BLUETONGUE VIRUS; BONE MARROW CELLS; CATTLE; CATTLE DISEASES; CELLS, CULTURED; CRICETINAE; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; INTERFERON TYPE I; MICE, INBRED C57BL; SHEEP; THYMUS GLAND;

EID: 84891685562     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02697-13     Document Type: Article

References (39)

1. Schwartz-Cornil I, Mertens PP, Contreras V, Hemati B, Pascale F, Breard E, Mellor PS, MacLachlan NJ, Zientara S. 2008. Bluetongue virus: virology, pathogenesis and immunity. Vet. Res. 39:46. http://dx.doi.org/10.1051/vetres:2008023.
2. Mellor PS, Baylis M, Mertens PP. 2009. Bluetongue. Academic Press, London, United Kingdom.
3. Roy P. 2005. Bluetongue virus proteins and particles and their role in virus entry, assembly, and release. Adv. Virus Res. 64:69-123. http://dx.doi.org/10.1016/S0065-3527(05)64004-3.
4. Ratinier M, Caporale M, Golder M, Franzoni G, Allan K, Nunes SF, Armezzani A, Bayoumy A, Rixon F, Shaw A, Palmarini M. 2011. Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog. 7:e1002477. http://dx.doi.org/10.1371/journal.ppat.1002477.
5. Maclachlan NJ, Guthrie AJ. 2010. Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases. Vet. Res. 41:35. http://dx.doi.org/10.1051/vetres/2010007.
6. MacLachlan NJ. 1994. The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp. Immunol. Microbiol. Infect. Dis. 17:197-206. http://dx.doi.org/10.1016/0147-9571(94)90043-4.
7. Barratt-Boyes SM, MacLachlan NJ. 1994. Dynamics of viral spread in bluetongue virus infected calves. Vet. Microbiol. 40:361-371. http://dx.doi.org/10.1016/0378-1135(94)90123-6.
8. Hemati B, Contreras V, Urien C, Bonneau M, Takamatsu HH, Mertens PP, Breard E, Sailleau C, Zientara S, Schwartz-Cornil I. 2009. Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 83:8789-8799. http://dx.doi.org/10.1128/JVI.00626-09.
9. Jeggo MH, Wardley RC. 1982. Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types. Immunology 45:629-635.
10. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
11. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307-336. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115843.
12. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010.
13. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
14. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345. http://dx.doi.org/10.1128/JVI.01080-07.
15. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384. http://dx.doi.org/10.1038/ni.1863.
16. Clarke CJ, Trapani JA, Johnstone RW. 2001. Mechanisms of interferon mediated anti-viral resistance. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1:117-130. http://dx.doi.org/10.2174/1568008013341361.
17. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921. http://dx.doi.org/10.1126/science.8009221.
18. Calvo-Pinilla E, Rodriguez-Calvo T, Anguita J, Sevilla N, Ortego J. 2009. Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One 4:e5171. http://dx.doi.org/10.1371/journal.pone.0005171.
19. Chauveau E, Doceul V, Lara E, Adam M, Breard E, Sailleau C, Viarouge C, Desprat A, Meyer G, Schwartz-Cornil I, Ruscanu S, Charley B, Zientara S, Vitour D. 2012. Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases. J. Virol. 86:11789-11799. http://dx.doi.org/10.1128/JVI.00430-12.
20. Johansson C, Wetzel JD, He J, Mikacenic C, Dermody TS, Kelsall BL. 2007. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J. Exp. Med. 204:1349-1358. http://dx.doi.org/10.1084/jem.20061587.
21. Ruscanu S, Pascale F, Bourge M, Hemati B, Elhmouzi-Younes J, Urien C, Bonneau M, Takamatsu H, Hope J, Mertens P, Meyer G, Stewart M, Roy P, Meurs EF, Dabo S, Zientara S, Breard E, Sailleau C, Chauveau E, Vitour D, Charley B, Schwartz-Cornil I. 2012. The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway. J. Virol. 86:5817-5828. http://dx.doi.org/10.1128/JVI.06716-11.
22. Umeshappa CS, Singh KP, Nanjundappa RH, Pandey AB. 2010. Apoptosis and immuno-suppression in sheep infected with bluetongue virus serotype-23. Vet. Microbiol. 144:310-318. http://dx.doi.org/10.1016/j.vetmic.2010.02.033.
23. Odeón AC, Schore CE, Osburn BI. 1997. The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves. Comp. Immunol. Microbiol. Infect. Dis. 20:219-231. http://dx.doi.org/10.1016/S0147-9571(97)00004-0.
24. Quist CF, Howerth EW, Bounous DI, Stallknecht DE. 1997. Cell-mediated immune response and IL-2 production in white-tailed deer experimentally infected with hemorrhagic disease viruses. Vet. Immunol. Immunopathol. 56:283-297. http://dx.doi.org/10.1016/S0165-2427(96)05747-9.
25. Owens RJ, Limn C, Roy P. 2004. Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release. J. Virol. 78:6649-6656. http://dx.doi.org/10.1128/JVI.78.12.6649-6656.2004.
26. Mercier FE, Ragu C, Scadden DT. 2012. The bone marrow at the cross-roads of blood and immunity. Nat. Rev. Immunol. 12:49-60. http://dx.doi.org/10.1038/nri3132.
27. Segovia JC, Guenechea G, Gallego JM, Almendral JM, Bueren JA. 2003. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J. Virol. 77:8495-8503. http://dx.doi.org/10.1128/JVI.77.15.8495-8503.2003.
28. Althof N, Whitton JL. 2013. Coxsackievirus b3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors. J. Virol. 87:2823-2834. http://dx.doi.org/10.1128/JVI.03004-12.
29. La Russa VF, Innis BL. 1995. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin. Haematol. 8:249-270. http://dx.doi.org/10.1016/S0950-3536(05)80240-9.
30. Manchester M, Smith KA, Eto DS, Perkin HB, Torbett BE. 2002. Targeting and hematopoietic suppression of human CD34+ cells by measles virus. J. Virol. 76:6636-6642. http://dx.doi.org/10.1128/JVI.76.13.6636-6642.2002.
31. Lang PA, Cervantes-Barragan L, Verschoor A, Navarini AA, Recher M, Pellegrini M, Flatz L, Bergthaler A, Honda K, Ludewig B, Ohashi PS, Lang KS. 2009. Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 113:1045-1052. http://dx.doi.org/10.1182/blood-2007-10-117861.
32. Elbers AR, Backx A, Meroc E, Gerbier G, Staubach C, Hendrickx G, van der Spek A, Mintiens K. 2008. Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. Prev. Vet. Med. 87:21-30. http://dx.doi.org/10.1016/j.prevetmed.2008.06.004.
33. Rojas JM, Rodriguez-Calvo T, Pena L, Sevilla N. 2011. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep. Vaccine 29:6848-6857. http://dx.doi.org/10.1016/j.vaccine.2011.07.061.
34. Foulon E, Foucras G. 2008. Two populations of ovine bone marrowderived dendritic cells can be generated with recombinant GM-CSF and separated on CD11b expression. J. Immunol. Methods 339:1-10. http://dx.doi.org/10.1016/j.jim.2008.07.012.
35. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92. http://dx.doi.org/10.1016/S0022-1759(98)00204-X.
36. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-211. http://dx.doi.org/10.1126/science.1235214.
37. Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL. 1999. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur. J. Immunol. 29:2367-2375. http://dx.doi.org/10.1002/(SICI)1521-4141(199908)29:08>2367::AID-IMMU2367<3.0.CO;2-3.
38. Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson JA. 1996. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919-925.
39. Barratt-Boyes SM, Rossitto PV, Stott JL, MacLachlan NJ. 1992. Flow cytometric analysis of in vitro bluetongue virus infection of bovine blood mononuclear cells. J. Gen. Virol. 73(Pt 8):1953-1960. http://dx.doi.org/10.1099/0022-1317-73-8-1953.